This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2009 May;157(5):825-6.

doi: 10.1016/j.ahj.2009.02.021.

New precompetitive paradigms: focus on cardiac safety

John Finkle, Daniel Bloomfield, Kathleen Uhl, Wendy Sanhai, Norman Stockbridge, Mitchell W Krucoff

PMID: 19376307
DOI: 10.1016/j.ahj.2009.02.021

Editorial

New precompetitive paradigms: focus on cardiac safety

John Finkle et al. Am Heart J. 2009 May.

. 2009 May;157(5):825-6.

doi: 10.1016/j.ahj.2009.02.021.

Authors

John Finkle, Daniel Bloomfield, Kathleen Uhl, Wendy Sanhai, Norman Stockbridge, Mitchell W Krucoff

PMID: 19376307
DOI: 10.1016/j.ahj.2009.02.021

No abstract available

PubMed Disclaimer

Comment on

Assessing proarrhythmic potential of drugs when optimal studies are infeasible.
Rock EP, Finkle J, Fingert HJ, Booth BP, Garnett CE, Grant S, Justice RL, Kovacs RJ, Kowey PR, Rodriguez I, Sanhai WR, Strnadova C, Targum SL, Tsong Y, Uhl K, Stockbridge N. Rock EP, et al. Am Heart J. 2009 May;157(5):827-36, 836.e1. doi: 10.1016/j.ahj.2009.02.020. Am Heart J. 2009. PMID: 19376308 Review.

Similar articles

A stitch in time saves nine.
Chopra PS. Chopra PS. J Invasive Cardiol. 2002 Jan;14(1):13. J Invasive Cardiol. 2002. PMID: 11773689 No abstract available.
Chimeric technologies.
Malik P. Malik P. Can J Cardiol. 2000 Nov;16(11):1375-6. Can J Cardiol. 2000. PMID: 11109034 No abstract available.
The torch passes.
Timmis GC. Timmis GC. J Interv Cardiol. 2005 Jun;18(3):145-6. doi: 10.1111/j.1540-8183.2005.00036.x. J Interv Cardiol. 2005. PMID: 15966915 No abstract available.
Cardionomics: a new integrative approach for screening cardiotoxicity of drug candidates.
Gwathmey JK, Tsaioun K, Hajjar RJ. Gwathmey JK, et al. Expert Opin Drug Metab Toxicol. 2009 Jun;5(6):647-60. doi: 10.1517/17425250902932915. Expert Opin Drug Metab Toxicol. 2009. PMID: 19442031 Review.
[Advances in ischaemic heart disease].
Alegria E, Velasco A, Azcárate P. Alegria E, et al. Rev Med Univ Navarra. 2005 Jul-Sep;49(3):16-30. Rev Med Univ Navarra. 2005. PMID: 16400973 Review. Spanish.

See all similar articles

Cited by

Assessing cardiac safety in oncology drug development.
Seltzer JH, Gintant G, Amiri-Kordestani L, Singer J, Koplowitz LP, Moslehi JJ, Barac A, Yu AF. Seltzer JH, et al. Am Heart J. 2019 Aug;214:125-133. doi: 10.1016/j.ahj.2019.04.010. Epub 2019 May 4. Am Heart J. 2019. PMID: 31202099 Free PMC article. Review. No abstract available.
The Role of the Food and Drug Administration in Drug Development: On the Subject of Proarrhythmia Risk.
Thind M, Kowey PR. Thind M, et al. J Innov Card Rhythm Manag. 2020 Jan 15;11(1):3958-3967. doi: 10.19102/icrm.2020.110103. eCollection 2020 Jan. J Innov Card Rhythm Manag. 2020. PMID: 32368365 Free PMC article. Review.
A Framework for Exception From Informed Consent in Trials Enrolling Patients With ST-Segment-Elevation Myocardial Infarction and Cardiogenic Shock.
Nichol G, Dickert NW, Moeller JE, Hochman JS, Facemire C, Adams KN, Stone GW, Morrow DA, Thiele H, Henry TD, Simonton C, Rao SV, O'Neill W, Gilchrist I, Egelund R, Proudfoot A, Waksman R, West NEJ, Sapirstein JS, Krucoff MW. Nichol G, et al. J Am Heart Assoc. 2025 Mar 4;14(5):e037946. doi: 10.1161/JAHA.124.037946. Epub 2025 Feb 26. J Am Heart Assoc. 2025. PMID: 40008533 Free PMC article.
Effect of small angiokinase inhibitor nintedanib (BIBF 1120) on QT interval in patients with previously untreated, advanced renal cell cancer in an open-label, phase II study.
Eisen T, Shparyk Y, Macleod N, Jones R, Wallenstein G, Temple G, Khder Y, Dallinger C, Studeny M, Loembe AB, Bondarenko I. Eisen T, et al. Invest New Drugs. 2013 Oct;31(5):1283-93. doi: 10.1007/s10637-013-9962-7. Epub 2013 Apr 27. Invest New Drugs. 2013. PMID: 23625328 Clinical Trial.
[Polypharmacy is of major concern in cardiology].
Dovjak P, Sommeregger U, Otto R, Roller RE, Böhmdorfer B, Iglseder B, Benvenuti-Falger U, Lechleitner M, Gosch M. Dovjak P, et al. Wien Med Wochenschr. 2010 Jun;160(11-12):264-269. doi: 10.1007/s10354-010-0784-3. Wien Med Wochenschr. 2010. PMID: 20640922 Review. German.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
Medical
- MedlinePlus Health Information